300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology VC Funds & Investors in France (May 2026)

The most active venture capital funds investing in France Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in France Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bpifrance
VC Fund
46 France, United States, Switzerland Seed, Series A Software, Health Care, Information Technology $643k–$29M
Karista
VC Fund
24 France, United States, Norway Seed, Series A, Series B Software, Biotechnology, Health Care $321k–$32M
GO CAPITAL
VC Fund
24 France, Canada, Israel Seed, Series A Biotechnology, Software, Health Care $504k–$6.4M
Kurma Partners
VC Fund
23 France, Spain, Switzerland Series A, Seed, Series B Health Care, Biotechnology, Medical $2.1M–$80M
Seventure Partners
VC Fund
22 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $2.4M–$35M
Auriga Partners
VC Fund
19 France, United States, Switzerland Series B, Series A Biotechnology, Health Care, Medical $2.1M–$31M
Sofinnova Partners
VC Fund
18 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $4.4M–$57M
Idinvest Partners
VC Fund
16 France, United States, Spain Series B, Series A Biotechnology, Software, Health Care $3.2M–$53M
Omnes Capital
VC Fund
15 France, United States, Belgium Series A, Series B Software, Biotechnology, Health Care $3.2M–$37M
Elaia
VC Fund
13 France, United States, Spain Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $857k–$27M
Sofimac Investment Managers
VC Fund
12 France, Italy, Austria Seed, Series A Biotechnology, Health Care, Manufacturing $268k–$14M
AdBio partners
VC Fund
11 France, Belgium, Spain Seed, Series A Biotechnology, Health Care, Pharmaceutical $2.1M–$29M
AQUITI Gestion
VC Fund
10 France, United States Seed, Series A Biotechnology, Software, Manufacturing $170k–$12M
Cap Innov'Est
VC Fund
9 France Seed, Series A Biotechnology, Pharmaceutical, Health Care $536k–$7.5M
Inserm Transfert Initiative
VC Fund
9 France, Switzerland, United States Series A, Series B, Seed Biotechnology, Medical, Health Care $1.1M–$35M
Galia Gestion
VC Fund
8 France, United States Series A, Seed Manufacturing, Software, Biotechnology $536k–$7M
Sham Innovation Santé
VC Fund
7 France Series B, Series A Biotechnology, Medical Device, Medical $5.6M–$80M
BNP Paribas
VC Fund
6 France, United Kingdom, India Debt Financing, Post-IPO Debt Financial Services, Information Technology, Software $7M–$3.8B
IRDI
VC Fund
6 France Series A, Series B Health Care, Software, Biotechnology $1.6M–$21M
Pontifax
VC Fund
6 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.8M–$100M
Crédit Agricole
VC Fund
6 France, United States, Italy Seed, Debt Financing Software, Health Care, Internet $536k–$1.2B
WiSEED
VC Fund
6 France Seed, Equity Crowdfunding Software, Manufacturing, Biotechnology $321k–$2.9M
M Capital Partners
VC Fund
6 France, United States, Canada Seed, Series A Health Care, Food and Beverage, Software $643k–$27M
Caisse d’Epargne
VC Fund
6 France Debt Financing, Seed Health Care, Biotechnology, Manufacturing $400k–$279M
Paca Investissement
VC Fund
6 France Seed, Series A Software, Internet, Manufacturing $321k–$2.9M
CEA Investissement
VC Fund
5 France, Canada, United States Seed, Series A Biotechnology, Manufacturing, Electronics $16k–$6.8M
Starquest Capital
VC Fund
5 France, Singapore, The Netherlands Seed, Series A Software, Information Technology, Manufacturing $281k–$11M
Normandie Participations
VC Fund
5 France Seed, Series A Software, Biotechnology, Health Care $429k–$11M
Crédit Mutuel Innovation
VC Fund
5 France, United States, Canada Series A, Series B Software, Health Care, Biotechnology $3.2M–$32M
Octalfa
VC Fund
5 France Seed, Series A Biotechnology, Health Care, Medical $643k–$3.7M
Angels Santé
VC Fund
5 France, India, United States Seed, Angel Health Care, Medical Device, Biotechnology $482k–$2.6M
IRDI SORIDEC Gestion
VC Fund
4 France Seed, Series A Biotechnology, Information Technology, Software $1.6M–$7.8M
Truffle Capital
VC Fund
4 France, United States, Belgium Series A, Series B Biotechnology, Financial Services, Health Care $2.5M–$21M
M Ventures
VC Fund
4 United States, Switzerland, United Kingdom Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.1M–$67M
Demeter
VC Fund
4 France, Germany, Slovenia Seed, Series A Software, Manufacturing, Renewable Energy $1.1M–$16M
Pertinence Invest
VC Fund
4 France Seed Biotechnology, Medical, CRM $107k–$4.3M
Supernova Invest
VC Fund
4 France, Switzerland Series A, Seed Health Care, Medical Device, Software $1.5M–$18M
BNP Paribas Développement
VC Fund
4 France, Germany Series A, Series B Software, Information Technology, Health Care $2.7M–$60M
Emertec
VC Fund
4 France, Canada, United States Series A, Series B Software, Biotechnology, Energy $1.4M–$15M
XAnge
VC Fund
4 France, Germany, United States Series A, Seed, Series B Software, SaaS, Information Technology $857k–$43M
Meusinvest (Noshaq)
VC Fund
4 Belgium, France, Germany Seed, Series A Health Care, Biotechnology, Medical $134k–$15M
Societe Generale Asset Management
VC Fund
4 France, United States, Germany Series B, Series A Biotechnology, Software, Health Care $1.8M–$54M
Casdin Capital
VC Fund
4 United States, France, China Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $6.4M–$191M
Agrinvest
VC Fund
4 France, United States, Belgium Series B, Series A Software, Biotechnology, E-Commerce $1.4M–$16M
Finovam Gestion
VC Fund
4 France, United States Seed, Series A Software, Information Technology, Medical Device $493k–$3.9M
ACG Management
VC Fund
4 France, Madagascar Seed, Series A Software, Health Care, Biotechnology $857k–$7.1M
Andera Partners
VC Fund
3 France, United States, Germany Series B, Private Equity Biotechnology, Health Care, Medical $11M–$241M
Norgine Ventures
VC Fund
3 France, United Kingdom, United States Debt Financing, Series A Health Care, Medical Device, Biotechnology $2.5M–$16M
Siparex Groupe
VC Fund
3 France, United States, Italy Private Equity, Seed Manufacturing, Software, Information Technology $643k–$31M
Investisseurs privés
VC Fund
3 France Seed, Series A Software, SaaS, Information Technology
Access all 592 VC funds in France Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 46 investments in France Biotechnology startups, 117 in the past 12 months

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 667
  • Round size: Seed $643k–$5.4M; Series A $2M–$29M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Nonna Lab — Make the Most. Le laboratoire qui vous rend la vie meilleure.
  • Altior — Altior is an IT company that offers cloud industrial management software and ERP solution.
  • Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 24 investments in France Biotechnology startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Norway

Investor stats

  • Total investments: 129
  • Round size: Seed $321k–$2.8M; Series A $1.1M–$4.3M; Series B $2.5M–$32M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Bfore.AI — Starting from patented technology developed in years of research, BforeAi is the prediction service that looks for newly registered or morphed domains, and score their maliciousness looking at metadata and links to other bad guys.
  • Exotrail — Exotrail is an end-to-end space mobility operator. Our mission is to enable small satellites to move in space, optimise their deployment, increase their service performance, and reduce space pollution.
  • Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
Show all investments...

GO CAPITAL
VC Fund · Rennes, Bretagne, France · 24 investments in France Biotechnology startups, 8 in the past 12 months

GO CAPITAL is a management company approved by the AMF and a member of AFIC. It is based in Rennes, and manages more than 130 million of assets by investing primarily in western France in innovative companies with high growth potential.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A
  • Geography: France, Canada, Israel

Investor stats

  • Total investments: 104
  • Round size: Seed $504k–$4.2M; Series A $1.7M–$6.4M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
  • Episto — Episto helps you collect ultra-authentic insights from your targets, anywhere in the world, simply and instantly
  • Kanta — Kanta provides an anti-money laundering technology that automates data gathering and processing operations while maintaining standard compliance. Kanta automates time-consuming activities and manages AML regulatory monitoring.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 23 investments in France Biotechnology startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Spain, Switzerland

Investor stats

  • Total investments: 95
  • Round size: Seed $2.1M–$7.5M; Series A $2.1M–$50M; Series B $4.1M–$80M
  • Lead/follow: 53% lead, 47% follow
  • Last fund: May invest from a new fund soon — raised $89M in 2020

Portfolio highlights

  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • Kiro — Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 22 investments in France Biotechnology startups, 7 in the past 12 months

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 175
  • Round size: Series A $2.4M–$18M; Series B $3M–$35M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Allozymes — Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzymedevelopment to the next level.
  • Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Show all investments...

Auriga Partners
VC Fund · Paris, Ile-de-France, France · 19 investments in France Biotechnology startups

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 126
  • Round size: Series A $2.1M–$14M; Series B $3.8M–$31M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $45M in 2013

Portfolio highlights

  • Patrowl — Identify and harden your External Security Posture with the leader. Let us manage time-consuming tasks and focus on remediation
  • Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.
  • Vade Secure — Vade is a global leader in predictive email defense, protecting 1 billion inboxes worldwide. AI-based email security for Microsoft 365.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 18 investments in France Biotechnology startups, 21 in the past 12 months

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Series A $4.4M–$53M; Series B $7M–$57M; Series C $10M–$54M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 16 investments in France Biotechnology startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series B, Series A
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 217
  • Round size: Series A $3.2M–$15M; Series B $7.4M–$53M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $86M in 2021

Portfolio highlights

  • Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • BreezoMeter — BreezoMeter offers personalized air quality & pollen data as well as active fire alerts with worldwide coverage & accuracy down to the street level.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 15 investments in France Biotechnology startups, 9 in the past 12 months

Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 152
  • Round size: Series A $3.2M–$21M; Series B $4M–$37M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $407M in 2020

Portfolio highlights

  • Iktos — Iktos is the only company to offer generative modeling with built-in synthetic accessibility for successful drug discovery
  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
  • The Exploration Company — For Space & Non-Space Industries.
Show all investments...

Elaia
VC Fund · Paris, Ile-de-France, France · 13 investments in France Biotechnology startups, 15 in the past 12 months

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 151
  • Round size: Seed $857k–$5.4M; Series A $2M–$21M; Series B $3.5M–$27M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Aviwell — Aviwell’s mission is to develop healthy, native, natural, and sustainable solutions to improve animal health and growth to better nourish the planet ... At a fraction of the cost.
  • Hema.to — Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
  • Greenbids — Reducing digital advertising carbon emissions with machine learning.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sofimac Investment Managers
VC Fund · Clermont-ferrand, Auvergne, France · 12 investments in France Biotechnology startups

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: France, Italy, Austria

Investor stats

  • Total investments: 72
  • Round size: Seed $268k–$1.9M; Series A $1.6M–$14M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Blue Valet — Blue Valet is a provider of valet parking-parking at airports and train stations.
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
  • Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Show all investments...

AdBio partners
VC Fund · Paris, Ile-de-France, France · 11 investments in France Biotechnology startups, 6 in the past 12 months

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: France, Belgium, Spain

Investor stats

  • Total investments: 21
  • Round size: Seed $2.1M–$5.9M; Series A $20M–$29M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely still investing — raised $106M in 2021

Portfolio highlights

  • Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • Anoat Therapeutics — Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.
Show all investments...

AQUITI Gestion
VC Fund · Bordeaux, Aquitaine, France · 10 investments in France Biotechnology startups

Acteur incontournable du capital-investissement en Nouvelle-Aquitaine

Show more...

Investment focus

  • Industry: Biotechnology, Software, Manufacturing
  • Stage:Seed, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 42
  • Round size: Seed $170k–$5.9M; Series A $300k–$12M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $6.2M in 2010

Portfolio highlights

  • Emulseo — Emulseo is a startup company dedicated to the design and production of high-quality formulations for microfluidic applications. The company's service is based upon long-time know-how and expertise in the field of microfluidics for the pharmaceutical, biotech, and chemical industry.Emulseo was established in 2018 in Pessac,Nouvelle-Aquitaine.
  • Pony — Instant city bike hire
  • Germitec SAS — Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system.
Show all investments...

Cap Innov'Est
VC Fund · Illkirch-graffenstaden, Alsace, France · 9 investments in France Biotechnology startups

Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 17
  • Round size: Seed $536k–$2.7M; Series A $7.3M–$7.5M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $39M in 2014

Portfolio highlights

  • Defymed — Defymed is a worldwide leader in the development of innovative implantable medical devices that change the paradigm of therapeutics' administration. Defymed's innovations were developed to limit adverse events related to current standard of care based on site specific delivery of therapeutics. Our solutions aim for a preciseadministration of drugs, in a physiologic site, in order to improve disease's management and patients' quality of life. Up to date, two first in class technologies were developed by Defymed: MailPan®, a physiologic cell encapsulation device, and ExOlin®, a targeted drug delivery device (in clinics). Defymed owns an exclusive technology and know-how which positions its medical devices as a platform to meet several therapeutic applications, among which type 1 diabetes, hemophilia and cancer management. Defymed is certified ISO13485:2016. Defymed relies also on a strong and unique worldwide network gathering experts from the cell therapy and drug delivery fields. Defymed has been rewarded several times in Europe and in the USA, for its unique approaches to reinvent patients' journey.
  • VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
  • Opencell Software — Opencell is an agile monetization platform that makes it easy for businesses to quickly launch, grow and manage recurring revenue businesses.
Show all investments...

Inserm Transfert Initiative
VC Fund · Paris, Ile-de-France, France · 9 investments in France Biotechnology startups

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: France, Switzerland, United States

Investor stats

  • Total investments: 21
  • Round size: Seed $2.7M–$3.6M; Series A $1.1M–$35M; Series B $2.1M–$30M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
  • VectivBio — VectivBio is a clinical-stage biotechnology company bringing transformational medicines to patients with serious rare diseases. They are committed to pursuing rare diseases with well-defined biology that can be targeted with best-in-disease therapies that have the potential to meaningfully transform and improve the lives of patients and theirfamilies, not just provide an incremental improvement or benefit over the standard-of-care.It was founded as a spinout from Therachon, a biotechnology company acquired by Pfizer for its program in achondroplasia. VectivBio was incorporated in 2019 and is based in Basel, Switzerland.
  • Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.
Show all investments...

Galia Gestion
VC Fund · Bordeaux, Aquitaine, France · 8 investments in France Biotechnology startups

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Biotechnology
  • Stage:Series A, Seed
  • Geography: France, United States

Investor stats

  • Total investments: 54
  • Round size: Seed $536k–$2.9M; Series A $536k–$7M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Wizaly — Optimize the ROI of your marketing mix based on our 100% data driven view of the performance of your marketing channels.Unlock the Power of Marketing Analytics at Wizaly.com: Optimize Your Marketing Campaigns, Maximize ROI, and Understand the Customer Journey. Discover actionable insights and data-driven strategies to drive your business forward. Start your journey to marketing success today!
  • Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
  • Germitec SAS — Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system.
Show all investments...

Sham Innovation Santé
VC Fund · Lyon, Rhone-Alpes, France · 7 investments in France Biotechnology startups

Relyens is the leading European mutual group specialising in risk management services for health and social care professionals as well as for local authorities.

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, Medical
  • Stage:Series B, Series A
  • Geography: France

Investor stats

  • Total investments: 16
  • Round size: Series A $5.6M–$72M; Series B $9.6M–$80M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
  • Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
  • Germitec SAS — Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system.
Show all investments...

BNP Paribas
VC Fund · Paris, Ile-de-France, France · 6 investments in France Biotechnology startups, 37 in the past 12 months

BNP Paribas provides banking, financing, investment, savings, and protection solutions. Their investment services include businesses that provide savings, investment, and protection services. They provide financing and investment services to retail customers, associations, businesses, and corporations.

Show more...

Investment focus

  • Industry: Financial Services, Information Technology, Software
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, United Kingdom, India

Investor stats

  • Total investments: 111
  • Round size: Post-IPO Debt $38M–$3B; Debt Financing $7M–$3.8B
  • Lead/follow: 21% lead, 79% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Mirakl — Mirakl offers the industry’s advanced enterprise marketplace SaaS platform. With Mirakl, organizations across B2B and B2C industries can launch marketplaces faster, grow bigger, and operate with confidence as they exceed rising customer expectations. Platforms are the new competitive advantage in eCommerce, and the world’s most trusted brandschoose Mirakl for its comprehensive solution of technology, expertise, and the Mirakl Connect ecosystem to unlock the power of the platform business model for them. As a result, companies like ABB, Astore by AccorHotels, Best Buy Canada, Carrefour, Catch, Changi Airport, Darty, The Kroger Co., Leroy Merlin, Maisons du Monde, Metro, and Toyota Material Handling gain the speed, scale, and agility to win in the changing eCommerce landscape. For more information: www.mirakl.com.
  • Altior — Altior is an IT company that offers cloud industrial management software and ERP solution.
  • Shanghai Chemical Industry Park Industrial Gases — Shanghai Chemical Industry Park Industrial Gases is a professional land developer that offers integrated development, construction, operation, and support services, among other services.
Show all investments...

IRDI
VC Fund · Toulouse, Midi-Pyrenees, France · 6 investments in France Biotechnology startups

IRDI Gestion is a private equity and venture capital institution.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Series B
  • Geography: France

Investor stats

  • Total investments: 36
  • Round size: Series A $1.6M–$21M; Series B $3.1M–$6.5M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
  • Mon Chasseur Immo — Mon Chasseur Immo is a Real Estate, based in Languedoc Roussillon.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 6 investments in France Biotechnology startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 93
  • Round size: Series A $3.8M–$72M; Series B $16M–$100M; Series C $12M–$75M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
  • ARMGO,Pharma,Inc. — ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on thesarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Crédit Agricole
VC Fund · Paris, Ile-de-France, France · 6 investments in France Biotechnology startups, 13 in the past 12 months

Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.

Show more...

Investment focus

  • Industry: Software, Health Care, Internet
  • Stage:Seed, Debt Financing
  • Geography: France, United States, Italy

Investor stats

  • Total investments: 108
  • Round size: Seed $536k–$4.3M; Debt Financing $1.6M–$1.2B
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • 4.71 — 4.71 is a system that allows to connect all of the technologies used in business financial management. Collections, purchases, overheads, payroll, pre-accounting, and even the accounting production tool can all be automated.
  • Muule — Muule, an ethical outdoor equipment distributor, examines companies before distributing them. Each brand sold on the site is subject to an eco-responsibility barometer that considers three important indicators: product eco-design, manufacturing chain, and corporate social responsibility (CSR).
  • Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
Show all investments...

WiSEED
VC Fund · Toulouse, Midi-Pyrenees, France · 6 investments in France Biotechnology startups

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Biotechnology
  • Stage:Seed, Equity Crowdfunding
  • Geography: France

Investor stats

  • Total investments: 27
  • Round size: Seed $321k–$2.9M; Equity Crowdfunding $455k–$2.7M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Dianosic — Dianosic was founded in 2017 and develops innovative solutions in the field of ENT (Ear, Nose & Throat), a $50 billion, double digit growth, and still largely underserved market. Our startup operates right at the frontier between Medtech and Biotech, as we see tremendous opportunities for drug-device combinations in this specialty. The projectoriginates from the ENT Department from the University Hospital of Strasbourg, where unmet clinical needs have been identified. Our main focus areas are Chronic Rhinitis, Chronic Sinusitis and intranasal bleeding (Epistaxis). Noteworthy, Dianosic has a strong French and German footprint in R&D and manufacturing.Dianosic’s strategic goal is to establish new standards of care in Chronic Rhinitis and Chronic Sinusitis with its drug-eluting Active Resorbable Scaffold (ARIS). This drug-device combination ARIS platform, developed with world renowned resorbable polymers experts, has the potential to establish new treatment paradigms. Moreover, our ARIS platform creates immense opportunities to create other verticals, especially in the field of chronic migraine and facial pain.Beside this, Dianosic commercialize an Asymmetric Intranasal inflatable solution (CAVI-T) for the treatment of intranasal bleeding, a widespread condition in ENT that affects 10% of the population. This CE marked and FDA registered technology addresses a clear unmet need and demonstrated our ability not only to develop a differentiated technology in record time, but also to successfully transition from R&D to Sales. We are currently present in relevant markets in EU and paving the way to launch in the U.S. in the mid term. Noteworthy, since our main call point is the ENT, CAVI-T prepares the ground for our upcoming ARIS platform.
  • VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
  • BiPER Therapeutics — BiPER Therapeutics : First-In-Class Therapeutics to Treat Cancer. Biotech company founded in 2021 to develop and commercialize novel therapeutics.
Show all investments...

M Capital Partners
VC Fund · Toulouse, Midi-Pyrenees, France · 6 investments in France Biotechnology startups

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Show more...

Investment focus

  • Industry: Health Care, Food and Beverage, Software
  • Stage:Seed, Series A
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 97
  • Round size: Seed $643k–$5M; Series A $1.9M–$27M
  • Lead/follow: 64% lead, 36% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Ellona — Ellona develops environmental intelligence solutions-based devices for outdoor and indoor spaces. Its solutions help decision-makers improve their environments through the use of sensors capable of analyzing and monitoring both air quality and nuisances.
  • Olino — Olino is the insurance for tomorrow's SME. A digital service, a turnkey solution tailored to VSBs and SMEs, meeting all insurance needs.
  • Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
Show all investments...

Caisse d’Epargne
VC Fund · Paris, Ile-de-France, France · 6 investments in France Biotechnology startups, 7 in the past 12 months

Caisse d’Epargne is a cooperative bank that supports all economic players. It shares its values ​​of social responsibility and humanism with its member customers. It is committed to the heart of the regions, the 15 regional savings banks are involved on a daily basis in their clients' projects and provide them with tailor-made solutions.Ithas now had 4.8 million members and 20.6 million customers, managed by 4,182 bank branches and the My Online Banker branch.It was created in 1818 and is headquartered in Paris, France.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Debt Financing, Seed
  • Geography: France

Investor stats

  • Total investments: 38
  • Round size: Seed $400k–$6.4M; Debt Financing $429k–$279M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • BiOceanOr — BiOceanOr provides underwater weather stations to measure water quality. Their solutions provide informations from your exploitation in real-time. Receive alerts in real-time and take decisions with their preventive alert system.
  • Oncodesign — Pharmacological expertise for anticancer therapies from target to patient : a unique oncology preclinical CRO.Founded in 1995, Oncodesign is a biopharmaceutical company that fills in the innovation gaps in the healthcare industry, based on its unique precision medicine platform. Technological innovation lies at the heart of Oncodesign’smodel—the Etiology, Discovery and Experimentation activities designed and implemented by Oncodesign contribute to a more effective approach to the phenomenon of innate and acquired resistance, more effective treatments and a reduction in therapeutic failures.Working alongside big pharma, biotech’s, public research institutions and investment groups, Oncodesign orients the research and development of new therapeutic and diagnostic tools. Through its range of services, partnerships and licensing programs, Oncodesign’s offering can meet the full range of innovation needs.Oncodesign is listed on the Euronext Growth Paris market and possesses a stable ownership structure with a majority owner committed to its development.
  • Monet Associes — Monet + Associes is a public relations agency.
Show all investments...

Paca Investissement
VC Fund · Paris, Ile-de-France, France · 6 investments in France Biotechnology startups

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

Show more...

Investment focus

  • Industry: Software, Internet, Manufacturing
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 73
  • Round size: Seed $321k–$1.6M; Series A $402k–$2.9M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
  • SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
  • C4Diagnostics — C4Diagnostics developed a fast, reliable detection of microorganisms. Our Click-chemistry technology is at the core of our portfolio of diagnostic tests.
Show all investments...

CEA Investissement
VC Fund · Paris, Ile-de-France, France · 5 investments in France Biotechnology startups

CEA Investissement (SA), founded (as CEA Valorisation) in 1999, is a subsidiary of the CEA, a major player in technological research, development and innovation. The central mission of CEA Valorisation is to create economic value based on technological innovations. To fulfill this mission, they have developed two main activities: Investmentin seed capital in innovative start-ups / start-ups active in the technology areas of CEA. The Licensing of advising companies and public laboratories of innovation in creative strategy development and marketing rights to patent or know-how belonging to the CEA, other research organizations or innovative companies. In addition, CEA contributes to the financing of national investment in seed technology (activity "Fund of Funds"), this activity is developed through particular Emertec management and funds managed by this company (FCPR Emertec 2 Emertec Energy and Environment), the FCPR managed by ACE Security Management SA, an investment company in seed priming Minatec SAS. Their areas of technological expertise are mainly micro-and nanotechnology, health technologies, the New Technologies for Information and Communication (NTIC), advanced materials and technologies for energy.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Electronics
  • Stage:Seed, Series A
  • Geography: France, Canada, United States

Investor stats

  • Total investments: 17
  • Round size: Seed $16k–$3.9M; Series A $1.4M–$6.8M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • ISORG — Complete solutions provider of self-manufactured hardware & software for fingerprint matching on large area & smartphones. Higher security with multiple fingers authentications.
  • EnobraQ — EnobraQ is a start-up created in 2015, from a pre-competitive research project supported by Toulouse White Biotechnology (TWB). Concerned with ecological and economic considerations, EnobraQ develops breakthrough technologies that use CO2 and target markets as diverse as nutrition, agri-food, cosmetics, pharmacology and bioplastics.
  • ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
Show all investments...

Starquest Capital
VC Fund · Paris, Ile-de-France, France · 5 investments in France Biotechnology startups

Starquest Capital is a venture capital firm based in France that helps accelerate the growth of entrepreneurs.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Series A
  • Geography: France, Singapore, The Netherlands

Investor stats

  • Total investments: 101
  • Round size: Seed $281k–$2.1M; Series A $552k–$11M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — raised $54M in 2021

Portfolio highlights

  • Beeldi — Beeldi is THE fastest and most complete digital diagnostic solution on the market. Beeldi digitizes wealth management and allows you to exploit your data over time.
  • Cailabs — Cailabs is a French deep tech company, based in Rennes, which designs, produces and sells photonic solutions to fully exploit the industrial potential opened up by the shaping of light.Cailabs develops and produces a unique range of optical components based on its know-how and its patented technological innovations, in particular Multi-PlaneLight Conversion (MPLC).
  • Caeli Énergie — Caeli Énergie develops and manufactures next-generation air conditioners with great energy efficiency and a minimal carbon impact.
Show all investments...

Normandie Participations
VC Fund · Colombelles, Basse-Normandie, France · 5 investments in France Biotechnology startups

Normandie Participations is a venture capital fund that co-invests in companies based in Normandy. It invests through equity and quasi-equity in small and medium-sized enterprises. The firm was founded in 2016 and is based in Colombelles, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 26
  • Round size: Seed $429k–$2.3M; Series A $1.6M–$11M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • GreenBig — GreenBig is a manufacturer of smart plastic bottle collection kiosks
  • Aurora Cold Plasma Sterilisation — Aurora Cold Plasma Sterilisation provides low temperature plasma sterilator for medical and research purposes.
Show all investments...

Crédit Mutuel Innovation
VC Fund · Paris, Ile-de-France, France · 5 investments in France Biotechnology startups

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 77
  • Round size: Series A $3.2M–$21M; Series B $7.5M–$32M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Worldia — Worldia is an online travel agency.
  • Kenko — Kenko is an application that helps to provide corporate health insurance.
  • Glopal — Glopal provides advanced international Google shopping solutions for ecommerce retailers and brands seeking to grow their businesses' globally.
Show all investments...

Octalfa
VC Fund · Écully, Rhone-Alpes, France · 5 investments in France Biotechnology startups

Octalfa is a France-based venture capital firm that offers a range of financial services.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 17
  • Round size: Seed $643k–$2.1M; Series A $1.5M–$3.7M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Mathym — Mathym - a nanotechnology company dedicated to the development, manufacturing and commercialization of nanomaterials and nanodispersions.
  • Amolyt Pharma — We are building on our team's established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases.
  • ORPHELIA Pharma — ORPHELIA Pharma is a French pharmaceutical company dedicated to the development and marketing of pediatric drugs for oncology and CNS diseases. ORPHELIA’s mission is to significantly improve essential medicines administered to children through the development of efficient, reliable and safe drugs with child-friendly formulations. We focus ondeveloping optimized formulations for the pediatric population of approved drugs as well as obtaining the approval for existing drugs in new pediatric orphan indications.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Angels Santé
VC Fund · Puteaux, Ile-de-France, France · 5 investments in France Biotechnology startups

Angels Santé is a networking site for investors and companies in the health sector.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Angel
  • Geography: France, India, United States

Investor stats

  • Total investments: 19
  • Round size: Seed $482k–$2.6M; Angel $643k–$1.3M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
  • Odimma — Empowering personalized immunotherapy to treat cancer
  • Ensweet — Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation.
Show all investments...

IRDI SORIDEC Gestion
VC Fund · 4 investments in France Biotechnology startups

IRDI SORIDEC Gestion

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Software
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 22
  • Round size: Seed $1.6M–$5.9M; Series A $3.7M–$7.8M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • EasyPicky — Easypicky provides quick image identification technology that improves planogram control from any on-board system.
  • Nimbl'bot — Nimbl'bot argues that robotics can help to protect the health of manual workers. Its robots are designed to handle the most time-consuming and risky activities, allowing humans to focus on higher-value duties.
  • getfluence — Discover Getfluence, the global sponsored content marketplace, and make headlines on premium media. Buy and get your SEO backlinks today.
Show all investments...

Truffle Capital
VC Fund · Paris, Ile-de-France, France · 4 investments in France Biotechnology startups

Business Builders, Truffle

Show more...

Investment focus

  • Industry: Biotechnology, Financial Services, Health Care
  • Stage:Series A, Series B
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 52
  • Round size: Series A $2.5M–$13M; Series B $2.7M–$21M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $150M in 2019

Portfolio highlights

  • Obat — Obat is a saas solution provider that uses software for contractors and self-employed for invoicing.
  • Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
  • MoneyTrack — MoneyTrack is a global, decentralized blockchain platform for Directed Money.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 4 investments in France Biotechnology startups, 17 in the past 12 months

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 119
  • Round size: Seed $2.1M–$18M; Series A $6M–$42M; Series B $9.5M–$67M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
  • BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
  • Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Show all investments...

Demeter
VC Fund · Paris, Ile-de-France, France · 4 investments in France Biotechnology startups, 16 in the past 12 months

Demeter is a major player in venture capital and private equity for the energy and ecological transition. They invest from 500 K€ to 30 M€ to support companies at all stages of their development: innovative startups, high growth SMEs and infrastructure projects.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Renewable Energy
  • Stage:Seed, Series A
  • Geography: France, Germany, Slovenia

Investor stats

  • Total investments: 69
  • Round size: Seed $1.1M–$4.3M; Series A $7M–$16M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • E-Recycle — E-Recycle is an online and offline store that specializes in recycling used high-tech products such as mobile phones, tablets, and PCs.
  • Plan A — Automate your company's ESG and carbon footprint reporting and reduce your emissions. Create decarbonisation plans plans based on data and science.
  • BeFC Bioenzymatic Fuel Cells — Miniature batteries are complex, expensive and unecological to collect and recycle. Our thin, light-weight and flexible paper-based biofuel cells are biodegradable, environmentally friendly and economically viable.
Show all investments...

Pertinence Invest
VC Fund · Villeurbanne, Rhone-Alpes, France · 4 investments in France Biotechnology startups

Pertinence Invest is an investment Firm that works with tech start ups.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, CRM
  • Stage:Seed
  • Geography: France

Investor stats

  • Total investments: 9
  • Round size: Seed $107k–$4.3M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • BIOMAE — BIOMAE provides biomonitoring tools to measure contamination and toxicity of aquatic environments. The company presents tools for measuring and monitoring the quality of aquatic environments from markers of effects on a pollutant invertebrate transplanted directly into the environment. The biomonitoring tools come from years of research, making itpossible to analyze the bioavailability of the contaminants and the degree of toxicity, directly in the medium. The company operates a methodological breakthrough to identify the issue of diagnosis for environmental quality monitoring.BIOMAE was founded on 2014 and is based in Gaillard, France.
  • Skinjay — Skinjay presents you with an opportunity to combine a priceless moment of well-being with a daily ritual: SHOWERING.Thanks to a concept that offers an innovative and particularly effective method for diffusing essential oils into shower water, Skinjay helps you benefit from the positive effects of Aromatherapy and Aromachology directly on yourbody and through inhalation, all the while you enjoy an intense moment of well-being in the shower.Adopt Skinjay, install the Module in your shower very easily, and choose the essential oil shower capsules depending on your wishes and needs on the day.The Aromachology capsules from the ODYSSEY collection will stimulate your senses and take you on an intense emotional journey to the heart of your memories, while the Aromatherapy capsules from the MISSION collection.Will ease the minor ailments of your daily life thanks to the recognised beneficial qualities of essential oils.
  • Mablink Bioscience — Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
Show all investments...

Supernova Invest
VC Fund · Paris, Ile-de-France, France · 4 investments in France Biotechnology startups

we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Software
  • Stage:Series A, Seed
  • Geography: France, Switzerland

Investor stats

  • Total investments: 48
  • Round size: Seed $1.5M–$7.5M; Series A $3.8M–$18M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $155M in 2021

Portfolio highlights

  • Aniah — Aniah specializes in chip design closure and full-chip analysis at the transistor level.
  • Allotex — Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.
  • ProovStation — Vehicle inspection gantry: save money and time by automating your vehicle inspection process and damages recognition to boost your productivity!
Show all investments...

BNP Paribas Développement
VC Fund · Paris, Ile-de-France, France · 4 investments in France Biotechnology startups, 7 in the past 12 months

BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Series B
  • Geography: France, Germany

Investor stats

  • Total investments: 91
  • Round size: Series A $2.7M–$11M; Series B $8.6M–$60M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Agriodor — Agriodor is to provide concrete and effective alternatives to insecticides to help farmers produce more sustainably.
  • FHE Group — Focused on environmental issues, FHE develops intelligent energy management solutions. It is by taking control of household consumption that the energy balance improves. The advanced features of our solutions (thermostatic programming and domestic hot water (ECS)) facilitate the use of solar energy. With the self-consumption of the energy producedby solar panels, participating in the energy transition is no longer a utopia. The mission of FHE is to design and develop intelligent energy management solutions that are sustainable and controlled.
  • Beem Energy — Beem Energy is a manufacturer of home energy efficiency and energy management systems such as solar kits.
Show all investments...

Emertec
VC Fund · Grenoble, Rhone-Alpes, France · 4 investments in France Biotechnology startups

EMERTEC’s experienced investment team has developed proven track record and has been able to develop close ties with major industrial players, many of them also being investors in their funds.These close ties are extremely valuable as to understand medium and long-term requirements of major order placers and high-level commercial opportunities.This brings visibility and confidence for entrepreneurs as well as for its investors.Their objective is to create value by turning ground-breaking technological innovations into commercial and financial successful companies.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Energy
  • Stage:Series A, Series B
  • Geography: France, Canada, United States

Investor stats

  • Total investments: 22
  • Round size: Series A $1.4M–$6.8M; Series B $5.7M–$15M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Ynsect — We are the world leader in insect ingredient production for animals, people, and plants. Our goal? To make the way we eat more nutritious and sustainable.
  • eLichens — eLichens is a sensor tech company that takes sensor technology to the next level. Its mission is to empower people, companies, and government agencies to improve air quality, both indoor and outdoor.
  • Osmia — Osmia SAS provides crop pollination services to improve yield and quality of agricultural production. Osmia intervenes in the context of specific problems on entomophilous or anemophilic pollination. Methodological approach and experience enables the company to find relevant solutions. It offers pollination studies and services for pre-base, baseor multiplication seeds. It also offers simple and efficient pollination services for arboriculture and optimize the yields and the quality of the productions of fruit trees.Osmia SAS was founded on 2014 and is headquartered in France.
Show all investments...

XAnge
VC Fund · Paris, Ile-de-France, France · 4 investments in France Biotechnology startups, 10 in the past 12 months

For 20 years, XAnge has been a key venture capital fund in Europe. With 70 startups in its portfolio, XAnge invests early in innovative tech companies.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: France, Germany, United States

Investor stats

  • Total investments: 159
  • Round size: Seed $857k–$7.4M; Series A $3M–$15M; Series B $6M–$43M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $236M in 2021

Portfolio highlights

  • Animaj — Explore the future of storytelling where AI meets creativity at Animaj Lab. Join us on a journey to revolutionize kids' entertainment, crafting captivating content that keeps the digital-first generation engaged and inspired.
  • elba — elba is the ultimate experience to secure your team in their daily work.
  • Smart Tribune — Smart-platform is a turnkey solution that allows a company / association / e-merchant to establish a conversational space directly with its user community. Present on the entire site of a company / association / e-merchant Smart Platform will enable to gather opinions, suggestions, problems, praise, and exploit them toimprove service, reduce cost of its customer service and increase its conversion rate. In the trend of Social CRM, Smart -tribune is based on a simple and intuitive interface for its users and allows great mastery thanks to an advertiser perspective administration interface. An effective way to better know your community, your customers in order to better the satisfy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 4 investments in France Biotechnology startups, 10 in the past 12 months

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 54
  • Round size: Seed $134k–$4M; Series A $1.1M–$15M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • RISORCE — RISORCE fills a need in Belgium for local solutions for processing tire waste while remaining dedicated to a circular economy strategy. We provide a regionally-based, technologically and environmentally sound solution.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Societe Generale Asset Management
VC Fund · Paris, Ile-de-France, France · 4 investments in France Biotechnology startups

SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series B, Series A
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 47
  • Round size: Series A $1.8M–$54M; Series B $2.1M–$15M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Augure — Augure by Launchmetrics' software and social data help brands and agencies to bridge the gap between traditional PR and Influencer Marketing. Every day, more than 1,000 Communication, PR, and Public Affairs teams use the Publisher platform to engage relevant influencers, manage their campaigns, improve efficiency and increase their presence inthe media and on social networks.The Augure by Launchmetrics' data services team compliments the Publisher software as the people behind the technology, offering consulting services that help clients to make sense of the data and apply it to their Influencer Marketing strategies.Founded in 2002 in Paris, Augure operates in Europe and Latin America. Its clients include Orange, Thales, AG Insurance, Pierre & Vacances, Château de Versailles, Amalthea, Hill+Knowlton and many others that span across the corporate sector.
  • Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
  • METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
Show all investments...

Casdin Capital
VC Fund · New York, New York, United States · 4 investments in France Biotechnology startups, 11 in the past 12 months

Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets undermanagement.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, France, China

Investor stats

  • Total investments: 171
  • Round size: Series A $6.4M–$191M; Series B $34M–$150M; Series C $33M–$175M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Octave — Octave has developed the first of it's kind precision care solution focused on neurodegenerative diseases beginning with Multiple Sclerosis (MS).
  • ROME Therapeutics — ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier inbiology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning.
  • Orbital Therapeutics — Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible.
Show all investments...

Agrinvest
VC Fund · Paris, Ile-de-France, France · 4 investments in France Biotechnology startups

Aurinvest is a venture capital fund it is managed and primarily funded by more than fifty entrepreneurs and business leaders, alongside with institutional investors. The company's goal is to invest in high growth companies or ventures which are on the edge of an exciting journey. It accompanies the founders in successfully carrying out theirplan. With this purpose, each holding is coached by two experienced professionals who stay in close contact with companies' management and who interface with Aurinvest's network.

Show more...

Investment focus

  • Industry: Software, Biotechnology, E-Commerce
  • Stage:Series B, Series A
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 32
  • Round size: Series A $1.4M–$5.8M; Series B $2.6M–$16M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Famoco — Famoco provides an Enterprise Mobility Management (EMM) solution with a range of secure, remotely managed Android devices. Famoco offers...
  • PathoQuest — PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing
  • Evercontact — Let Evercontact connect the dots in your life by turning your emails into an always-updated address book!
Show all investments...

Finovam Gestion
VC Fund · Villeneuve, Provence-Alpes-Cote d'Azur, France · 4 investments in France Biotechnology startups

Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.

Show more...

Investment focus

  • Industry: Software, Information Technology, Medical Device
  • Stage:Seed, Series A
  • Geography: France, United States

Investor stats

  • Total investments: 26
  • Round size: Seed $493k–$3.9M; Series A $536k–$3.8M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Ensweet — Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation.
  • OverSOC — OverSOC is a CAASM cybersecurity software that enables you to quickly aggregate and correlate data from your other cybersecurity tools: asset management, vulnerability management, endpoint detection and response, and more.
  • Miraxess — Discover how Miraxess's cutting-edge B2B solutions can revolutionize your business operations. Explore our lapdocks and docking station now!
Show all investments...

ACG Management
VC Fund · Marseille, Provence-Alpes-Cote d'Azur, France · 4 investments in France Biotechnology startups

Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: France, Madagascar

Investor stats

  • Total investments: 49
  • Round size: Seed $857k–$2.8M; Series A $1.5M–$7.1M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2013

Portfolio highlights

  • Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
  • Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
  • My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.
Show all investments...

Andera Partners
VC Fund · Paris, Ile-de-France, France · 3 investments in France Biotechnology startups, 9 in the past 12 months

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Private Equity
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 146
  • Round size: Series B $11M–$75M; Private Equity $107M–$241M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Ariceum Therapeutics — Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Show all investments...

Norgine Ventures
VC Fund · Uxbridge, Hillingdon, United Kingdom · 3 investments in France Biotechnology startups

Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Debt Financing, Series A
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 17
  • Round size: Debt Financing $2.5M–$16M
  • Lead/follow: 82% lead, 18% follow

Portfolio highlights

  • ImaginAb — ImaginAb is a pioneering biotech company, innovating for tomorrow with modern radiopharmaceutical advances. Our advanced imaging solutions like CD8 ImmunoPET are aimed to accelerate the progress of physicians all over the world, ending the need for repeat, painful biopsies.
  • PathoQuest — PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing
  • Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
Show all investments...

Siparex Groupe
VC Fund · Paris, Ile-de-France, France · 3 investments in France Biotechnology startups

Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Information Technology
  • Stage:Private Equity, Seed
  • Geography: France, United States, Italy

Investor stats

  • Total investments: 114
  • Round size: Seed $643k–$6.4M; Private Equity $5.4M–$31M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — raised $500M in 2021

Portfolio highlights

  • SILEANE — SILEANE is robotics, vision, and artificial intelligence. They offer to build machines to automate. They provide services that include robotique, vision industrielle, robotique adaptative, automatisation du geste, pick place, dévracage, traitement de surface, and intelligence artificielle.
  • Orcan Energy — Orcan Energy is the leader in waste heat recovery technology.Orcan Energy GmbH was founded in 2008, as a spin-out from the Technical University of Munich (“TUM”). Orcan’s ePack offers a compact, service-reduced and cost- efficient “plug-and-play” waste heat power generator based on ORC-Technology. Spe- cific patented innovations enable Orcan topopularize the technology on the mass mar- ket. At the beginning of 2013, Orcan gained sponsorships from the Exist-Research- Transfer-Aid of the Federal Government of Germany and additional grants from the “Wissensfabrik” and various resources from the TUM.
  • Monet Associes — Monet + Associes is a public relations agency.
Show all investments...

Investisseurs privés
VC Fund · Blanquefort, Midi-Pyrenees, France · 3 investments in France Biotechnology startups

Investisseurs privés

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 42
  • Lead/follow: no public data

Portfolio highlights

  • Tollys — New TLR3 ligand for a personalized cancer immunotherapy. TOLLYS TL-532 ligand uses the tumor patient as a vaccine.
  • Clone (ex Not So Dark) — Not So Dark offers a food delivery industry solution that creates exclusively online brands.
  • LE DRIVE TOUT NU — LE DRIVE TOUT NU is a startup of Consumers services Buyer aid.
Show all investments...

Biotechnology VC funding in France at a glance

Stats across 657 deals from 592 investors.

592
investors
in France Biotechnology startups
657
deals
in France Biotechnology startups
$4.9M
median round
in France Biotechnology startups
37%
lead investors
lead at least one round
17%
Series A
most common funding stage

Access all 592 VC funds in France Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 592 VC funds investing in France Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists